文献速递间质性肺疾病呼吸道感染

特发性肺纤维化与COVID-19的遗传重叠

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19.
PubMed 文献 · Eur Respir J · 2022-07-07

该文指出COVID-19与特发性肺纤维化(IPF)存在正向遗传相关性,提示干扰素介导的天然免疫在感染应答和慢性疾病中均发挥作用,而负相关信号对药物靶点选择有提示意义。ILD患者死于COVID-19的风险更高。

要点

  • COVID-19与IPF存在正向遗传相关性,涉及干扰素介导的天然免疫。
  • 负向遗传相关信号对药物靶点选择具有提示意义。
  • 间质性肺疾病患者死于COVID-19的风险更高。

核心结论

  • COVID-19与IPF的正向遗传相关性指向两者在感染应答和慢性疾病中共同的干扰素介导天然免疫机制。
  • 负向相关的遗传信号对药物靶点选择具有提示意义。

主要发现

  • COVID-19与IPF存在正向遗传相关性,涉及干扰素介导的天然免疫。
  • 负向遗传相关信号对药物靶向有提示意义。
  • 间质性肺疾病个体死于COVID-19的风险更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Positive genetic correlations for COVID-19 and IPF point to interferon-mediated innate immunity in both response to infection and chronic disease whilst negatively correlated signals highlight implications for drug targeting https://bit.ly/37MMxZa Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long-lasting respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterised by an aberrant response to alveolar injury leading to progressive scarring of the lungs. Individuals with ILD are at a higher risk of death from COVID-19 [1].

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Allen RJ, Guillen-Guio B, Croot E, et al. Genetic overlap between idiopathic pulmonary fibrosis and COVID-19. Eur Respir J. 2022. PMID: 35595312. doi:10.1183/13993003.03132-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。